Identification of WTAP, a novel Wilms' tumour 1-associating protein

Human Molecular Genetics

Volumn 9, Issue 15, 2000, Pages 2231-2239

  Little, Natalie A ^a,b   Hastie, Nicholas D ^a   Davies, Rachel C ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; NUCLEOTIDE; UNCLASSIFIED DRUG; WILMS TUMOR 1 ASSOCIATING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CHROMOSOME 17; CHROMOSOME 6; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; GENETIC CONSERVATION; HOUSEKEEPING GENE; HUMAN; HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEPHROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE; YEAST;

ANIMALIA;

EID: 0034703394     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.hmg.a018914     Document Type: Article

References (48)

1. Wilms' tumour as a paradigm for the relationship of cancer to development
2. Donor splice-site mutations in WT1 are responsible for Frasier syndrome
3. A clinical overview of WT1 gene mutations
4. WT-1 is required for early kidney development
5. Multiple roles for the Wilms' tumour suppressor gene, WT1 in genitourinary development
6. A non-AUG translational initiation event generates novel WT1 isoforms
7. Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties
8. RNA editing in the Wilms' tumor susceptibility gene, WT1
9. Alternative splicing and genomic structure of the Wilms tumor gene WT1
10. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
11. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence
12. Modulation of DNA binding specificity by alternative splicing of the Wilms' tumour WT1 gene transcript
13. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains
14. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1
15. The transcriptional effect of Wt1 is modulated by choice of expression vector
16. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin
17. Subnuclear localization of WT1 in splicing or transcription domains is regulated by alternative splicing
18. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes
19. An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling
20. RNA binding by the Wilms Tumour suppressor zinc finger proteins
21. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product
22. + RNP
23. Physical and functional interaction between WT1 and p53 proteins
24. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1
25. Ciao 1 is a novel WD40 protein that interacts with the tumour suppressor protein WT1
26. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression
27. Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9
28. Inhibition of cellular proliferation by the Wilms tumour suppressor WT1 requires association with the inducible chaperone Hsp70
29. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer
30. Towards high resolution maps of the mouse and human genome-a facility for ordering markers to 0.1 cM resolution
31. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo
32. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development
33. The candidate Wilms' tumour gene is involved in genitourinary development
34. The genetics of Wilms' tumour-a case of disrupted development
35. The cellular organization of gene expression
36. Identification of protein antigens associated with the nuclear matrix and with clusters of interchromatin granules in both interphase and mitotic cells
37. Nuclear organization and gene expression
38. The dynamics of a pre-mRNA splicing factor in living cells
39. Transcription-dependent colocalization of the U1, U2, U4/U6, and U5 Snrnps in coiled bodies
40. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer
41. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma
42. Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia
43. The T-locus of the mouse
44. Regulation of the Wilms' tumor gene during spermatogenesis
45. Splicing factors associate with hyperphosphorylated RNA polymerase II in the absence of pre-mRNA
46. Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex
47. Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor that is similar to AP-1 that is distinct from GCN4
48. A high-resolution integrated physical, cytogenetic, and genetic map of human chromosome 11: Distal p13 to proximal p15.1